- Home
- AIR vs BLTE Comparison
AIR vs BLTE Comparison
Compare AIR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- BLTE
- Stock Information
- Founded
- AIR 1951
- BLTE 2018
- Country
- AIR United States
- BLTE United States
- Employees
- AIR N/A
- BLTE N/A
- Industry
- AIR Aerospace
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- AIR Industrials
- BLTE Health Care
- Exchange
- AIR Nasdaq
- BLTE Nasdaq
- Market Cap
- AIR 1.8B
- BLTE 2.1B
- IPO Year
- AIR 1988
- BLTE 2022
- Fundamental
- Price
- AIR $52.81
- BLTE $56.40
- Analyst Decision
- AIR Strong Buy
- BLTE Strong Buy
- Analyst Count
- AIR 6
- BLTE 4
- Target Price
- AIR $80.67
- BLTE $96.67
- AVG Volume (30 Days)
- AIR 444.4K
- BLTE 37.7K
- Earning Date
- AIR 03-27-2025
- BLTE 05-12-2025
- Dividend Yield
- AIR N/A
- BLTE N/A
- EPS Growth
- AIR N/A
- BLTE N/A
- EPS
- AIR N/A
- BLTE N/A
- Revenue
- AIR $2,682,500,000.00
- BLTE N/A
- Revenue This Year
- AIR $18.46
- BLTE N/A
- Revenue Next Year
- AIR $5.10
- BLTE N/A
- P/E Ratio
- AIR N/A
- BLTE N/A
- Revenue Growth
- AIR 21.07
- BLTE N/A
- 52 Week Low
- AIR $46.51
- BLTE $32.25
- 52 Week High
- AIR $76.34
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- AIR 38.03
- BLTE 39.21
- Support Level
- AIR $52.04
- BLTE $49.00
- Resistance Level
- AIR $55.05
- BLTE $60.21
- Average True Range (ATR)
- AIR 3.00
- BLTE 3.55
- MACD
- AIR -0.01
- BLTE -0.57
- Stochastic Oscillator
- AIR 54.83
- BLTE 41.67
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.